Could a pill replace IV drips for leukemia patients?

This phase 3 trial is testing whether an oral (pill) form of arsenic trioxide works as well as the standard IV form for consolidation therapy in people with a low-risk type of acute promyelocytic leukemia (APL). About 120 adults and teens who have already completed initial treatment will be randomly assigned to receive either the oral or IV version, plus another drug called ATRA. The goal is to see if the oral form is absorbed similarly, keeps cancer in remission, and improves quality of life by reducing hospital visits.